Lemaitre Vasculr Stock Price, News & Analysis

LeMaitre (Nasdaq: LMAT) reported strong Q4 2020 results, with sales of $37.5 million, a 24% increase year-over-year. Operating income surged 94% to $9.5 million, resulting in a net income of $7.0 million and earnings of $0.34 per diluted share. Debt was reduced by $21.5 million, improving the balance sheet. Despite gross margin slightly declining to 65%, the company achieved record sales driven by acquisitions and strong performance in the Americas. For Q1 2021, LeMaitre projects sales between $33.8 and $36.8 million, with an expected earnings per share of $0.24 to $0.31.

LeMaitre Vascular (Nasdaq:LMAT) is set to participate in four key investor conferences in February and March 2021. David Roberts, President, will present at:

• SVB Leerink's Global Healthcare Conference on February 26, 2021, at 8:40 AM EST
• Barclays Global Healthcare Conference on March 9, 2021, at 1:50 PM EST
• 33rd Annual Roth Conference on March 15, 2021, on demand
• Oppenheimer's Healthcare Conference on March 16, 2021, at 3:10 PM EDT

LeMaitre Vascular specializes in devices and services for peripheral vascular disease, helping over 200 million people globally.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) will release its fourth quarter 2020 financial results on February 25, 2021, post-market. A conference call is scheduled for the same day at 5:00 PM ET to discuss results and company outlook. Investors can dial in or access the call via a webcast at www.lemaitre.com/investor. LeMaitre is known for its devices addressing peripheral vascular disease, a condition impacting over 200 million individuals globally, and offers a diversified product portfolio for vascular surgeons.

LeMaitre Vascular (Nasdaq:LMAT) announced its participation in two upcoming investor conferences in January 2021. CFO JJ Pellegrino will present at the 23rd Annual Needham Virtual Growth Conference on January 11, 2021, at 11:30 AM ET, and at the Sidoti Winter 2021 Investor Conference on January 14, 2021, at 10:45 AM ET. The company, which specializes in devices for treating peripheral vascular disease, aims to inform and engage investors about its market position and growth strategies.

LeMaitre Vascular announced that President David Roberts will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 12:25 PM ET. The company specializes in devices and services for treating peripheral vascular disease, which impacts over 200 million people globally. LeMaitre develops both disposable and implantable vascular devices, focusing on the needs of vascular surgeons.

LeMaitre Vascular (Nasdaq:LMAT) announced its participation in two investor conferences this November. David Roberts, President, will present at the Stifel Virtual Healthcare Conference on November 16, 2020, at 8:00 AM ET. Meanwhile, JJ Pellegrino, Chief Financial Officer, is set to speak at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum on November 19, 2020, at 9:30 AM ET. LeMaitre Vascular specializes in devices for treating peripheral vascular disease, serving over 200 million people globally.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its Q3 2020 results with sales reaching $36.4 million, reflecting a 25% increase. Operating income surged 70% to $10.0 million, with a net income of $7.5 million, a 45% rise. The company declared a quarterly dividend of $0.095/share. Growth was driven by acquisitions and recovery in elective surgeries. However, gross margin fell to 62.3% from 69.3% a year prior. Guidance for Q4 anticipates sales between $34.0 million and $38.0 million.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced it will release its third quarter 2020 financial results on October 29, 2020, after market close. A conference call is scheduled for 5:00 PM EDT that day to discuss the financial results and the company's outlook. Interested parties can join the call at 844-239-5284 or access the live webcast through their investor relations website.

LeMaitre Vascular specializes in devices for the treatment of peripheral vascular disease, a condition impacting over 200 million people globally.

LeMaitre Vascular (Nasdaq: LMAT) announced its participation in three investor conferences throughout September 2020. JJ Pellegrino, CFO, will engage in the Barrington Research Virtual Fall Investment Conference on September 9, followed by a presentation at the Cantor Virtual Global Healthcare Conference on September 15 at 4:00 PM EDT. Pellegrino will also present at the Sidoti Virtual Investor Conference on September 23 at 10:45 AM EDT. LeMaitre specializes in devices for treating peripheral vascular disease, impacting over 200 million globally.